• Cafiso V, Bertuccio T, Santagati M, Demelio V, Spina D, Nicoletti G & Stefani S (2007) agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus. FEMS Immunol Med Mic 51: 220227.
  • Ceri H, Olson ME, Stremick C, Read RR, Morck D & Buret A (1999) The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 17711776.
  • Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM & Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22: 9961006.
  • Clinical and Laboratory Standard Institute (CLSI) (2009) Performance Standard for Antimicrobial Susceptibility Testing. CLSI M100 and S19 Vol. 29 n. 3. CLSI, Wayne, PA.
  • Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 21: 13181322.
  • Dong Y, Zhao X, Domagala J & Drlica K (1999) Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob Agents Ch 43: 17561758.
  • Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167193.
  • Hajdu S, Lassnigg A, Graninger W, Hirschl AM & Presterl E (2009) Effects of vancomycin, daptomycin, fosfomycin, tigecycline and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthop Res 27: 13611365.
  • Hall-Stoodley L, Costerton JW & Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2: 95108.
  • Harrison JJ, Turner RJ, Marques LR & Ceri H (2005) Biofilms: a new understanding of these microbial communities is driving a revolution that may transform the science of microbiology. Am Sci 93: 508551.
  • Labthavikul P, Petersen PJ & Bradford PA (2003) In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Ch 47: 39673969.
  • Mah TF & O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 3439.
  • Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS & O'Toole GA (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426: 306310.
  • Patel R (2005) Biofilms and antimicrobial resistance. Clin Orthop Relat R 437: 4147.
  • Petersen PJ, Bradford PA, Weiss WJ, Murphy TM, Sum PE & Projan SJ (2002) In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob Agents Ch 46: 25952601.
  • Presterl E, Hajdu S, Lassnigg AM, Hirschl AM, Holinka J & Graninger W (2009) Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Ch 53: 32053210.
  • Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz RT & Hachem R (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Ch 51: 16561660.
  • Rose WE & Poppens PT (2009) Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemoth 63: 485488.
  • Sandoe JAT, Wysome J, West AP, Heritage J & Wilcox MH (2006) Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemoth 57: 767770.
  • Smith K, Perez A, Ramage G, Gemmell CG & Lang S (2009) Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Ag 33: 374378.
  • Zhao X & Drlica K (2001) Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 33: S147S156.
  • Ziebuhr W, Krimmer V, Rachid S, Lobner I, Gotz F & Hacker J (1999) A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of polysaccharide intercellular adhesin synthesis by alterning insertion and excision of the insertion sequence element IS256. Mol Microbiol 32: 345356.
  • Zimmerli W & Ochsner PE (2003) Management of infection associated with prosthetic joints. Infection 31: 99108.